Mechanisms of proton spin dephasing in a system of magnetic particles

Magnetic Resonance in Medicine

Volumn 66, Issue 6, 2011, Pages 1748-1758

  De Haan, Hendrick W ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

dephasing mechanisms; magnetic particles; MRI constrast agent; relaxivity; superparamagnetic nanoparticles

Indexed keywords

MONTE CARLO METHODS; NANOMAGNETICS;

CONSTRAST AGENT; DEPHASING; MAGNETIC PARTICLE; RELAXIVITY; SUPERPARAMAGNETIC NANOPARTICLES;

PARTICLE SIZE;

MAGNETIC NANOPARTICLE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; PROTON;

ARTICLE; DIFFUSION; DYNAMICS; MAGNETIC FIELD; MONTE CARLO METHOD; MOTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; PROTON SPIN DEPHASING; ROTATION; TIME;

EID: 79955376764     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.22966     Document Type: Article

References (23)

1. Veiseh O, Gunn JW, Zhang M,. Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. Adv Drug Deliv Rev 2010; 62: 284-304.
2. Kim J, Kim HS, Lee N, Kim T, Kim H, Yu T, Song IC, Moon WK, Hyeon T,. Multifunctional uniform nanoparticles composed of a magnetite nanocrystal core and a mesoporous silica shell for magnetic resonance and fluorescence imaging and for drug delivery. Angewandte Chem 2008; 120: 8438-8441.
3. Vries IJM, Lesterhuis WJ, Barentsz JO, Verdijk P, Krieken JH, Boerman OC, Oyen WJG, Bonenkamp JJ, Boezeman JB, Adema GJ, Bulte JWM, Scheenen TWJ, Punt CJA, Heerschap A, Figdor CG,. Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nature Biotechnol 2005; 23: 1407-1413.
4. Lee JH, Huh YM, Jun Y, Seo J, Jang J, Song HT, Kim S, Cho EJ, Yoon HG, Suh JS, Cheon J,. Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nature Med 2006; 13: 95-99.
5. Zhu J, Zhou L, XingWu FG,. Tracking neural stem cells in patients with brain trauma. New Engl J Med 2006; 355: 2376.
6. Hultman KL, Raffo AJ, Grzenda AL, Harris PE, Brown TR, OBrien S,. Magnetic resonance imaging of major histocompatibility class II expression in the renal medulla using immunotargeted superparamagnetic iron oxide nanoparticles. ACS Nano 2008; 2: 477-484.
7. Mazzucchelli S, Colombo M, Palma CD, Salvad A, Verderio P, Coghi MD, Clementi E, Tortora P, Corsi F, Prosperi D,. Single-domain protein A-engineered magnetic nanoparticles: toward a universal strategy to site-specific labeling of antibodies for targeted detection of tumor cells. ACS Nano 2010; 4: 5693-5702.
8. Brooks RA,. T2-shortening by strongly magnetized spheres: a chemical exchange model. Magn Reson Med 2002; 47: 388-391.
9. Gillis P, Moiny F, Brooks RA,. On T2-shortening by strongly magnetized spheres: a partial refocusing model. Magn Reson Med 2002; 47: 257-263.
10. Matsumoto Y, Jasanoff A,. T2 relaxation induced by clusters of superparamagnetic nanoparticles: Monte Carlo simulations. Magn Reson Imaging 2008; 26: 994-998.
11. Carroll MRJ, Woodward RC, House MJ, Teoh WY, Amal R, Hanley TL, Pierre TGS,. Experimental validation of proton transverse relaxivity models for superparamagnetic nanoparticle MRI contrast agents. Nanotechnology 2010; 21: 035103.
12. Chen DX, Sun N, Huang ZJ, Cheng CM, Xu H, Gu HC,. Experimental study on T2 relaxation time of protons in water suspensions of iron-oxide nanoparticles: effects of polymer coating thickness and over-low 1/T2. J Magn Magn Mater 2010; 322: 548-556.
13. Hardy PA, Henkelman RM,. Transverse relaxation rate enhancement caused by magnetic particulates. Magn Reson Imaging 1989; 7: 265-275.
14. Brown RJS,. Distribution of fields from randomly placed dipoles: free-precession signal decay as result of magnetic grains. Phys Rev 1961; 121: 1379-1382.
15. Yablonskiy DA, Haacke EM,. Theory of NMR signal behavior in magnetically inhomogeneous tissues: the static dephasing regime. Magn Reson Med 1994; 32: 749-763.
16. Brooks RA, Moiny F, Gillis P,. On T2-shortening by weakly magnetized particles: the chemical exchange model. Magn Reson Med 2001; 45: 1014-1020.
17. Weisskoff R, Zuo CS, Boxerman JL, Rosen BR,. Microscopic susceptibility variation and transverse relaxation: theory and experiment. Magn Reson Med 1994; 31: 601-610.
18. Boxerman JL, Hamberg LM, Rosen BR, Weisskoff RM,. MR contrast due to intravascular magnetic susceptibility perturbations. Magn Reson Med 1995; 34: 555-566.
19. LaConte LEW, Nitin N, Zurkiya O, Caruntu D, O'Connor CJ, Hu X, Bao G,. Coating thickness of magnetic iron oxide nanoparticles affects R2 relaxivity. J Magn Reson Imaging 2007; 26: 1634-1641.
20. Chen DX, Sun N, Gu HC,. Size analysis of carboxydextran coated superparamagnetic iron oxide particles used as contrast agents of magnetic resonance imaging. J Appl Phys 2009; 106: 063906.
21. Tromsdorf UI, Bigall NC, Kaul MG, Bruns OT, Nikolic MS, Mollwitz B, Sperling RA, Reimer R, Hohenberg H, Parak WJ, Förster S, Beisiegel U, Adam G, Weller H,. Size and surface effects on the MRI relaxivity of manganese ferrite nanoparticle contrast agents. Nano Lett 2007; 7: 2422-2427.
22. Duan H, Kuang M, Wang X, Wang YA, Mao H, Nie S,. Reexamining the effects of particle size and surface chemistry on the magnetic properties of iron oxide nanocrystals: New insights into spin disorder and proton relaxivity. J Phys Chem C 2008; 112: 8127-8131.
23. Pinho SLC, Pereira GA, Voisin P, Kassem J, Bouchaud V, Etienne L, Peters JA, Carlos L, Mornet S, Geraldes CFGC, Rocha J, Delville MH,. Fine tuning of the relaxometry of γ -Fe2O3@ SiO2 nanoparticles by tweaking the silica coating thickness. ACS Nano 4: 5339-5349.